ESC
A multi-active blend designed for healthy nerve function and comfort, built around PEA and alpha-lipoic acid with complementary botanical compounds and nutrients.
Studied formulation vs pregabalin 75 mg twice daily — mean VAS pain score (0–10) across a randomized, open-label study.
A multi-active blend built around PEA and alpha-lipoic acid, with complementary botanical compounds and supporting nutrients.
PEA · Alpha-lipoic acid — the primary multi-active base of the formulation.
Quercetin · AKBA · Isoflavones — plant-derived compounds studied for complementary support.
L-taurine · Phospholipids — studied for their role in healthy membrane structure.
Vitamin B12 · Folic acid · MSM round out the formulation as supporting nutrients.
These are potential positioning areas, not established Q-Axonivia health benefits. Product-specific substantiation is required.
A single delivery technology may not resolve every ingredient's limitations. Q-AXONIVIA pairs two QuanticSphere™ technologies — one for its phytosome actives, one for its minerals — giving brands a nerve-health proposition built around engineered delivery.
Phytosome-complexed nanosphere vesicles provide gastroprotective shielding, improved dissolution, enhanced uptake, and increased systemic exposure.
Minerals (Mg, Mn) are nano-chelated within a biopolymer matrix. They are protected from gastric conditions and released at intestinal pH for optimized mineral delivery.
Conventional nerve-health actives can face poor dissolution and limited systemic exposure. Q-AXONIVIA is designed to address that delivery challenge with dual QuanticSphere™ technology.
In a randomized, open-label study (n=40, 20 per arm) in adults with post-chikungunya neuropathic pain, the studied formulation reduced mean VAS pain scores by 64.9% at month 4, vs 52.8% for pregabalin 75 mg twice daily. 80% of subjects achieved at least a 50% VAS reduction (vs 60% for pregabalin), and 85% reported PGIC "much improved" (vs 65%).
QuanticSphere™ PQNS (Phytosome Quantum Nano Sphere) uses phytosome-complexed nanosphere vesicles for gastroprotective shielding, improved dissolution, enhanced uptake and increased systemic exposure. QuanticSphere™ MIBS (Mineral Ion Biopolymer Sphere) nano-chelates minerals (Mg, Mn) within a biopolymer matrix, protecting them from gastric conditions and releasing them at intestinal pH for optimized mineral delivery.
Healthy nerve function support, normal nerve sensation and comfort, and antioxidant support. These are potential positioning areas, not established Q-Axonivia health benefits — product-specific substantiation is required.
Facility: NSF/ANSI 455-2 certified GMP, FSSC 22000, ISO 9001/14001/45001. Regulatory: 21 CFR Part 111, Halal Certified. Dissolution: approximately 95–100% release, batch-consistent. IP: QuanticSphere™ PQNS, patent pending 202521095813.
Share your formulation requirements and our team can walk you through the full Q-Axonivia clinical dossier, supply format and technical specifications.
Talk to a Specialist